Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Durect Corp (DRRX)

2014-07-17@21:03:23 ET
DURECT CorporationCorporate Event Announcement Notice (WSH)

2014-07-16@21:02:44 ET
DURECT CorporationCorporate Event Announcement Notice (WSH)

2014-07-16@10:22:53 ET
Global Transdermal Drug Delivery Market 2014-2018 with ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen Pharma & Novartis Dominating (MTO)

2014-06-27@16:09:18 ET
Sector Update: Healthcare Lower; Allergan Defies Sector Hitting Record High on Deal With Pershing Square (MID)

2014-06-27@16:01:22 ET
Sector Update: Healthcare (MID)

2014-06-27@13:13:59 ET
Sector Update: Healthcare Stocks Drifting Lower; Vertex Pharma Falling Despite Recommendation For Additional Indications for Cystic Fibrosis Drug (MID)

2014-06-27@13:13:21 ET
Sector Update: Healthcare (MID)

2014-06-26@23:51:31 ET
8-K: DURECT CORP (EDK)

2014-06-26@16:05:00 ET
DURECT Secures $20 Million Debt Financing (PRN)

2014-06-26@03:34:11 ET
World Market for Pain Management Drugs and Devices to 2017 (MTO)

2014-06-10@08:00:38 ET
2014 Report on the International Pain Management Drugs Market - Forecasts to 2018 (MTO)

2014-06-09@08:00:00 ET
DURECT to Present at The Wall Street Analyst Forum Institutional Investor Conference (PRN)

2014-05-23@04:34:32 ET
Research and Markets: Global Neuropathic Pain Report 2014: Durect Corporation's Eladur - Forecast and Market Analysis to 2022 (BIZ)

2014-05-23@03:37:29 ET
Global Neuropathic Pain Report 2014: Durect Corporation's Eladur - Forecast and Market Analysis to 2022 (MTO)

2014-05-21@09:35:21 ET
DURECT Q1 net loss decreases (DTM)

2014-05-17@20:47:21 ET
DURECT CorporationCorporate Event Announcement Notice (WSH)

2014-05-16@20:53:33 ET
DURECT CorporationCorporate Event Announcement Notice (WSH)

2014-05-16@10:07:29 ET
8-K: DURECT CORP (EDK)

2014-05-16@08:30:00 ET
(PRN)

2014-05-07@13:26:27 ET
Chronic Pain - Pipeline Review, H1 2014: 61 Companies and 125 Drugs Profiled (MTO)